RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept

Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

Edlin, BR., Seal, KH., Lorvick, J., Kral, A., Ciccarone, DH., Moore, LD., & Lo, B. (2001). Is it justifiable to withhold treatment for hepatitis C from illicit-drug users? New England Journal of Medicine, 345(3), 211-215.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Presidential youth fitness program implementation
Article

Development and validation of prescription drug risk, efficacy, and benefit perception measures in the context of direct-to-consumer prescription drug advertising
Article

A prospective observational study of patient-reported functioning and quality of life in advanced and metastatic breast cancer utilizing a novel mobile application
Article

Identification and validation of major cardiovascular events in the United Kingdom data sources Included in a multi-database post-authorization safety study of prucalopride